Received May 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM / LA |
No actual sign of adverse event reported, however pt administered vaccine 5 months apart (not per guidelines). Pharmacy requires adverse reporting to VAERS since administered outside of guidelines.
no
no